Loading chat...

NJ A417

Bill

Status

Introduced

1/9/2024

Primary Sponsor

Robert Auth

Click for details

Origin

General Assembly

2024-2025 Regular Session

AI Summary

  • Requires pharmaceutical representatives who market or promote prescription drugs to practitioners to obtain a license from the State Board of Medical Examiners, with applicants being at least 18 years old, of good moral character, and completing a professional education course

  • Mandates 6 hours of continuing education every two years for license renewal, covering ethics, pharmacology, pharmaceutical marketing laws, prescription opioids, and alternatives to opioids for pain management

  • Requires pharmaceutical representatives to report to the board at least every two years: lists of practitioners contacted, frequency and duration of contacts, pharmaceuticals promoted, samples or gifts provided and their value, and any compensation given to practitioners

  • Prohibits deceptive or misleading marketing practices, misrepresenting professional credentials, and attending patient examinations without consent

  • Authorizes the board to suspend or revoke licenses for grossly unprofessional conduct or violations, with revoked licensees barred from relicensure for two years

Legislative Description

"Pharmaceutical Representative Licensing Act."

Regulated Professions

Last Action

Introduced, Referred to Assembly Regulated Professions Committee

1/9/2024

Committee Referrals

Regulated Professions1/9/2024

Full Bill Text

No bill text available